AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Canadian Cancer Trials Group
AstraZeneca
AstraZeneca
National Cancer Institute (NCI)
University College, London
AstraZeneca
National Cancer Institute (NCI)
AstraZeneca
AstraZeneca
AstraZeneca
AstraZeneca